Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Search by expertise, name or affiliation
Can we eliminate placebo in ALS clinical trials?
Zachary Simmons
Department of Neurology
Penn State Neuroscience Institute
Division of Neuromuscular Medicine
Research output
:
Contribution to journal
›
Comment/debate
›
peer-review
9
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Can we eliminate placebo in ALS clinical trials?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Amyotrophic Lateral Sclerosis
100%
Placebos
64%
Clinical Trials
60%
Therapeutics
15%